Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04273776 · ClinicalTrials.gov registry record · Early Phase 1
A Comparison of the Physiological and Behavioral Effects of Suvorexant and Zolpidem in Healthy Volunteers: A Randomized, Double-blind, Placebo Controlled Study
A Early Phase 1 study of Performance Enhancing Product Use, sponsored by Walter Reed Army Institute of Research (WRAIR).
- Active
- Registry status
- Early Phase 1
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT04273776 is a Early Phase 1 study of Performance Enhancing Product Use that is active but no longer recruiting, run by Walter Reed Army Institute of Research (WRAIR). The registered enrollment target is 90 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04273776, a Early Phase 1 study of Performance Enhancing Product Use, is active but no longer recruiting, sponsored by Walter Reed Army Institute of Research (WRAIR).
- ACTIVE NOT RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this study is to evaluate two pharmacotherapeutic approaches to sleep induction, both of which have been shown to be effective hypnotics, but may have unique side effect profiles. These profiles may have markedly different impacts on performance in a military setting. In this randomized, double-blind, placebo controlled study, the side effects of these drugs will be compared - suvorexant, a dual orexin receptor antagonist and zolpidem, a non-benzodiazepine gamma-aminobutyric acid (GABA) A agonist - in healthy controls comparable in age and gender to the target military population.
Conditions Studied
Interventions
- DRUG Suvorexant 10 mg
- DRUG Placebos
- DRUG Zolpidem
Study Locations (1)
Maryland
- Walter Reed Army Institute of Research - Silver Spring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2019-12-01 |
| Est. Completion | 2025-12-12 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04273776
The ClinicalTrials.gov registry entry for NCT04273776 describes a study currently listed as active not recruiting, categorized as Early Phase 1. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Walter Reed Army Institute of Research (WRAIR), which has 12 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Performance Enhancing Product Use appearing as the primary indexed condition, and to 3 interventions - of which Suvorexant 10 mg is the first listed.
NCT04273776 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT04273776 about?
NCT04273776 is a clinical study titled "A Comparison of the Physiological and Behavioral Effects of Suvorexant and Zolpidem in Healthy Volunteers: A Randomized, Double-blind, Placebo Controlled Study". The primary objective of this study is to evaluate two pharmacotherapeutic approaches to sleep induction, both of which have been shown to be effective hypnotics, but may have unique side effect profiles. These profiles may have markedly different impacts on performance in a military setting. In thi...
What is the current status of trial NCT04273776?
This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 90 participants. The study started on 2019-12-01. Estimated completion is 2025-12-12.
What conditions does trial NCT04273776 study?
This clinical trial studies the following conditions: Performance Enhancing Product Use.
What interventions are being tested in trial NCT04273776?
The interventions under investigation include: Suvorexant 10 mg (DRUG), Placebos (DRUG), Zolpidem (DRUG).
Who is sponsoring clinical trial NCT04273776?
This trial is sponsored by Walter Reed Army Institute of Research (WRAIR), which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04273776 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.